CD8A and cancer: In cancer, CD4 T cells have received less attention than CD8 T cells because tumor cells have reduced, and often lacking, expression of MHC-II molecules [9,10] and because the Class II-associated invariant chain peptide (CLIP) prevents presentation of endogenous peptides [11].